The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Activation of ROS/MAPK s /NF‐ κ B/NLRP3 and inhibition of efferocytosis in osteoclast‐mediated diabetic osteoporosis
Open accessAbstract
Diabetes mellitus (DM) affects bone metabolism and leads to osteoporosis; however, its pathogenetic mechanisms remain unknown. We found that high glucose (HG) conditions induced the production of reactive oxygen species (ROS) and the expression of proteins related to MAPKs [phosphorylated (p)‐ERK, p‐JNK, and p‐p38], NF‐ κ B(NF‐ κ B, p‐IαB, and IKK), and NACHT‐LRR‐PYD domains‐containing protein 3 (NALP3) (NLRP3) [apoptosis‐associated speck‐like protein containing a caspase activation and recruitment domain (ASC), caspase‐1, IL‐18, IL‐1β, and NLRP3] in osteoclasts (OCs) in vitro . Further analysis showed that in HG‐induced OCs, ROS is an upstream signal for MAPKs, NF‐ κ B, and the NLRP3 inflammasome. Moreover, MAPKs mediated the activation of NF‐ κ B and NLRP3, whereas NF‐ κ B up‐regulated the NLRP3 inflammasome response. Interestingly, HG inducement enhanced the bone resorption of OCs but inhibited their efferocytosis, whereas insulin and lipoxin A4 (4) treatment reversed this phenomenon. In streptozotocin‐induced diabetic rats in vivo , the numbers and the bone‐resorption capacity of OCs as well as the serum levels of TRACP‐5b were significantly increased, and the expression of MAPK‐, NF‐ κ B‐, and NLRP3 inflammasome‐related proteins in the proximal tibia were also significantly elevated; however, treatment with insulin and LXA4 reversed this elevation. Together, these results demonstrated that the activation of ROS/MAPK s /NF‐ κ B/NLRP3 and the inhibition of efferocytosis in OCs are the main causes of osteoporosis in DM.—An, Y., Zhang, H., Wang, C., Jiao, F., Xu, H., Wang, X., Luan, W., Ma, F., Ni, L., Tang, X., Liu, M., Guo, W., Yu, L. Activation of ROS/MAPK s /NF‐ κ B/NLRP3 and inhibition of efferocytosis in osteoclast‐mediated diabetic osteoporosis. FASEB J. 33, 12515–12527 (2019). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 2×
“At present, the drug treatments for osteoporosis, including estrogens, bisphosphonates, and selective estrogen-receptor modulators, target OC-mediated bone resorption, chiefly retarding BMD loss and thereby decreasing the risk of bone fractures (22, 24).”
BackgroundSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834
Control of osteoblast function and regulation of bone mass
Harada, S.-I., & Rodan, G. A. (2003) · Nature · doi:10.1038/nature01660 · Cited by 1,444
Oxidative stress, insulin signaling, and diabetes
Rains, J. L., & Jain, S. K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.006 · Cited by 1,435
The molecular understanding of osteoclast differentiation
Asagiri, M., & Takayanagi, H. (2007) · Bone · doi:10.1016/j.bone.2006.09.023 · Cited by 1,363
Apoptotic cell clearance: basic biology and therapeutic potential
Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223 · cited 1×
“Apoptotic neutrophils can inhibit macrophage inflammatory responses in vitro, whereas the failure to clear apoptotic cells exacerbates inflammation in vivo (20, 21), indicating that efferocytosis plays a crucial role in modulating the inflammatory response in macrophages (and other phagocytes) to promote inflammation…”
BackgroundMacrophage Phenotype and Function in Different Stages of Atherosclerosis
Tabas, I., & Bornfeldt, K. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306256 · Cited by 1,121 · cited 1×
“, “eat-me” signals, phosphatidylserine, and apolipoprotein E) with the assistance of bridgingmolecules (46, 47).”
BackgroundHorror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
Phagocyte partnership during the onset and resolution of inflammation
Soehnlein, O., & Lindbom, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2779 · Cited by 1,054
Saito, M., & Marumo, K. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1066-z · Cited by 906
Is NF-kappaB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · PubMed · Cited by 786
Is NF‐κB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1137 · Cited by 701
Douda, D. N., Khan, M. A., Grasemann, H., & Palaniyar, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414055112 · Cited by 693
Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
Youm, Y.-H., Grant, R. W., McCabe, L. R., Albarado, D. C., Nguyen, K. Y., Ravussin, A., Pistell, P., Newman, S., Carter, R., Laque, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.010 · Cited by 674
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., & Karin, M. (2005) · Nature · doi:10.1038/nature03491 · Cited by 626
Apoptosis: Activate NF-κB or die?
Baichwal, V. R., & Baeuerle, P. A. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00046-7 · Cited by 529
Fredman, G., Kamaly, N., Spolitu, S., Milton, J., Ghorpade, D., Chiasson, R., Kuriakose, G., Perretti, M., Farokhzad, O., & Tabas, I. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1065 · Cited by 357
Lu, H., Kraut, D., Gerstenfeld, L. C., & Graves, D. T. (2003) · Endocrinology · doi:10.1210/en.2002-220072 · Cited by 350
Ajizian, S. J., English, B. K., & Meals, E. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/314659 · Cited by 345
The role of NF-κB in the regulation of cell stress responses
Wang, T., Zhang, X., & Li, J. J. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00058-9 · Cited by 343
Diverse physiological functions for dual-specificity MAP kinase phosphatases
Dickinson, R. J., & Keyse, S. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03266 · Cited by 329
The clearance of dying cells: table for two
Green, D. R., Oguin, T. H., & Martinez, J. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.172 · Cited by 314
Diabetes Mellitus: Does it Affect Bone?
Schwartz, A. V. (2003) · Calcified Tissue International · doi:10.1007/s00223-003-0023-7 · Cited by 300
Thorp, E., Vaisar, T., Subramanian, M., Mautner, L., Blobel, C., & Tabas, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263020 · Cited by 298
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Viola, J. R., Lemnitzer, P., Jansen, Y., Csaba, G., Winter, C., Neideck, C., Silvestre-Roig, C., Dittmar, G., Döring, Y., Drechsler, M., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309492 · Cited by 226
Morimoto, K., Janssen, W. J., Fessler, M. B., McPhillips, K. A., Borges, V. M., Bowler, R. P., Xiao, Y.-Q., Kench, J. A., Henson, P. M., & Vandivier, R. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7657 · Cited by 215
Inflammasome Priming by Lipopolysaccharide Is Dependent upon ERK Signaling and Proteasome Function
Ghonime, M. G., Shamaa, O. R., Das, S., Eldomany, R. A., Fernandes-Alnemri, T., Alnemri, E. S., Gavrilin, M. A., & Wewers, M. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301974 · Cited by 206
IL-1 family cytokines trigger sterile inflammatory disease
Lukens, J. R., Gross, J. M., & Kanneganti, T.-D. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00315 · Cited by 172
Nassar, H. A., Kantarcı, A., & Dyke, T. E. V. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00168.x · Cited by 167
Suzuki, K., Zhu, B., Rittling, S. R., Denhardt, D. T., Goldberg, H. A., McCulloch, C. A., & Sodek, J. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1486 · Cited by 161
Fredman, G., Li, Y., Dalli, J., Chiang, N., & Serhan, C. N. (2012) · Scientific Reports · doi:10.1038/srep00639 · Cited by 127
Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation
Alippe, Y., Wang, C., Ricci, B., Xiao, J., Qu, C., Zou, W., Novack, D. V., Abu‐Amer, Y., Civitelli, R., & Mbalaviele, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-07014-0 · Cited by 114
Self-citationBrancaleone, V., Gobbetti, T., Cénac, N., Faouder, P. L., Colom, B., Flower, R. J., Vergnolle, N., Nourshargh, S., & Perretti, M. (2013) · Blood · doi:10.1182/blood-2013-04-496661 · Cited by 95
Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia
Liang, W., Luo, Z., Ge, S., Li, M., Du, J., Yan, M., Yan, M., Ye, Z., & Luo, Z. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.014 · Cited by 87
Bain, S. C., Ramamurthy, N., Impeduglia, T., Scolman, S., Golub, L. M., & Rubin, C. T. (1997) · Bone · doi:10.1016/s8756-3282(97)00104-x · Cited by 82
Hie, M., Yamazaki, M., & Tsukamoto, I. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.025 · Cited by 77
Garbin, U., Baggio, E., Stranieri, C., Pasini, A., Manfro, S., Mozzini, C., Vallerio, P., Lipari, G., Merigo, F., Guidi, G. C., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs301 · Cited by 76
Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone
Irwin, R., Lin, H. V., Motyl, K. J., & McCabe, L. R. (2006) · Endocrinology · doi:10.1210/en.2006-0700 · Cited by 69
Bone metabolism in type 2 diabetes and role of thiazolidinediones
Vestergaard, P. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328325d155 · Cited by 53
Lipoxin A4 inhibits UV radiation-induced skin inflammation and oxidative stress in mice
Martinez, R. M., Fattori, V., Saito, P., Melo, C. B. P., Borghi, S. M., Pinto, I. C., Bussmann, A. J. C., Baracat, M. M., Georgetti, S. R., Verri, W. A., Jr., et al. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.04.014 · Cited by 50
Diabetes mellitus and healing of closed fractures.
Am, H., Christensen, K., Nørgaard-Andersen, K., et al. (1992) · PubMed · Cited by 44
Wang, C., Qu, C., Alippe, Y., Bonar, S. L., Civitelli, R., Abu‐Amer, Y., Hottiger, M. O., & Mbalaviele, G. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.58 · Cited by 40
Self-citationToker, H. Ç., Özdemir, H., Balcı, H., & Özer, H. (2012) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2012.01497.x · Cited by 39
Mendis, E., Kim, M.-M., Rajapakse, N., & Kim, S.-K. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.037 · Cited by 30
Aziz, M., Yang, W., & Wang, P. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1431s100 · Cited by 25
Jaghsi, S., Hammoud, T., & Haddad, S. (2018) · The Open Rheumatology Journal · doi:10.2174/1874312901812010001 · Cited by 12
Jeong, D.-W., Kim, E., Kim, J., Lee, B., Hong, S., Park, J. H., Jung, H., & Sohn, Y. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3231784 · Cited by 7
Cited by
Bone fragility in diabetes: novel concepts and clinical implications
Hofbauer, L. C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Müller, R., Burden, A. M., Rivadeneira, F., Napoli, N., & Rauner, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00347-8 · Cited by 440
The initiation of oxidative stress and therapeutic strategies in wound healing
Wang, G., Yang, F., Zhou, W., Xiao, N., Luo, M., & Tang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114004 · Cited by 415
Iantomasi, T., Romagnoli, C., Palmini, G., Donati, S., Falsetti, I., Miglietta, F., Aurilia, C., Marini, F., Giusti, F., & Brandi, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043772 · Cited by 380
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
Yan, L., Wang, J., Cai, X., Liou, Y., Shen, H., Hao, J., Huang, C., Luo, G., & He, W. (2024) · MedComm · doi:10.1002/mco2.658 · Cited by 343
Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis
Yang, Y., Lin, Y., Wang, M., Yuan, K., Wang, Q., Mu, P., Du, J., Yu, Z., Yang, S., Huang, K., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00198-w · Cited by 259
Metadata
- Authors
- An, Y., Zhang, H., Wang, C., Jiao, F., Xu, H., Wang, X., Luan, W., Ma, F., Ni, L., Tang, X., Liu, M., Guo, W., & Yu, L.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2019-08-28
- Volume
- 33
- Issue
- 11
- Pages
- 12515-12527
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2970008479
- Cited by
- 408
- References
- 54
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.